<SEC-DOCUMENT>0001193125-18-298584-index.html : 20181015
<SEC-HEADER>0001193125-18-298584.hdr.sgml : 20181015
<ACCEPTANCE-DATETIME>20181012201006
ACCESSION NUMBER:		0001193125-18-298584
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180731
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181015
DATE AS OF CHANGE:		20181012

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		181121151

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d631911d8ka.htm
<DESCRIPTION>FORM 8-K/A
<TEXT>
Document 1 - file: d631911d8ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d631911dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: d631911dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d631911dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d631911dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>d631911dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 4 - file: d631911dex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>d631911dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
Document 5 - file: d631911dex993.htm

</DOCUMENT>
</SEC-DOCUMENT>